ISTITUTO GIANNINA GASLINI
🇮🇹Italy
- Country
- 🇮🇹Italy
- Ownership
- Private
- Established
- 1938-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.gaslini.org
Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Idiopathic Nephrotic Syndrome.
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-10-14
- Last Posted Date
- 2022-12-21
- Lead Sponsor
- Istituto Giannina Gaslini
- Target Recruit Count
- 160
- Registration Number
- NCT04585152
- Locations
- 🇮🇹
IRCCS G. Gaslini, Genova, Italy
Rituximab for Idiopathic Nephrotic Syndrome
- First Posted Date
- 2020-07-31
- Last Posted Date
- 2023-01-04
- Lead Sponsor
- Istituto Giannina Gaslini
- Target Recruit Count
- 30
- Registration Number
- NCT04494438
- Locations
- 🇮🇹
IRCCS Giannina Gaslini Institute, Genova, Italy
Efficacy of Anti-CD20 Antibodies (Rituximab Biosimilar) in the Treatment of Childhood Steroid-dependent Nephrotic Syndrome
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2020-05-27
- Last Posted Date
- 2020-09-14
- Lead Sponsor
- Istituto Giannina Gaslini
- Target Recruit Count
- 30
- Registration Number
- NCT04402580
- Locations
- 🇮🇹
IRCCS Istituto Giannina Gaslini, Genova, Italy
Stress CMR in Pediatric Patients With Suspected Coronary Artery Disease
- First Posted Date
- 2019-07-17
- Last Posted Date
- 2021-09-08
- Lead Sponsor
- Istituto Giannina Gaslini
- Target Recruit Count
- 15
- Registration Number
- NCT04022395
- Locations
- 🇮🇹
Istituto Giannina Gaslini, Genova, Italy
STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2018-11-02
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- Istituto Giannina Gaslini
- Target Recruit Count
- 260
- Registration Number
- NCT03728478
- Locations
- 🇮🇹
IRCCS Istituto Giannina Gaslini, Genova, GE, Italy
Postoperative Sore Throat in the Pediatric Population.
Completed
- Conditions
- First Posted Date
- 2018-01-04
- Last Posted Date
- 2019-08-08
- Lead Sponsor
- Istituto Giannina Gaslini
- Target Recruit Count
- 197
- Registration Number
- NCT03389776
- Locations
- 🇬🇧
Great Ormond Street Hospital, London, United Kingdom
IL-2 for Multi Drug Resistant Nephrotic Syndrome
- First Posted Date
- 2015-05-28
- Last Posted Date
- 2015-05-28
- Lead Sponsor
- Istituto Giannina Gaslini
- Target Recruit Count
- 5
- Registration Number
- NCT02455908
- Locations
- 🇮🇹
Istituto Giannina Gaslini, Genova, Italy
Prediction of Outcome of Lupus Nephritis
- Conditions
- Interventions
- First Posted Date
- 2015-03-31
- Last Posted Date
- 2020-07-29
- Lead Sponsor
- Istituto Giannina Gaslini
- Target Recruit Count
- 800
- Registration Number
- NCT02403115
- Locations
- 🇮🇹
IRCCS Giannina Gaslini Children Hospital, Genoa, Italy/GE, Italy
Ofatumumab in Children With Drug Resistant Idiopathic Nephrotic Syndrome
- First Posted Date
- 2015-03-20
- Last Posted Date
- 2020-07-29
- Lead Sponsor
- Istituto Giannina Gaslini
- Target Recruit Count
- 13
- Registration Number
- NCT02394106
- Locations
- 🇮🇹
IRCCS Istituto Giannina Gaslini, Genoa, Italy/GE, Italy
Ofatumumab Versus Rituximab in Children With Steroid and Calcineurin Inhibitor Dependent Idiopathic Nephrotic Syndrome
- First Posted Date
- 2015-03-20
- Last Posted Date
- 2020-07-30
- Lead Sponsor
- Istituto Giannina Gaslini
- Target Recruit Count
- 140
- Registration Number
- NCT02394119
- Locations
- 🇮🇹
IRCCS Istituto Giannina Gaslini, Genoa, Italy/GE, Italy
© Copyright 2024. All Rights Reserved by MedPath